Navigation Links
James B. Hawkins Appointed to IRIDEX Board of Directors
Date:10/15/2007

.

"I am pleased with the opportunity to join the Board of Directors of IRIDEX," said Mr. Hawkins. "IRIDEX has a solid portfolio of products, recently enhanced by the acquisition of the Laserscope aesthetics business, which has positioned them to achieve long-term, profitable growth. I look forward to working with the company and contributing to their progress."

Prior to Natus, Mr. Hawkins spent nearly 20 years as the president, CEO and a director of Invivo Corporation, a developer, manufacturer and marketer of multi-parameter vital sign monitoring equipment used in hospitals. Invivo was acquired by Intermagnetics General Corporation in 2004 at a 45% premium to its share price. Mr. Hawkins began his professional career by founding Corporate Financial Consulting Company, a specialized consultancy firm focused on assisting start-up and early-stage companies with all aspects of financial management and control. He earned a Bachelor of Commerce degree from Santa Clara University and an MBA from San Francisco State University.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 97 independent distributors into 107 countries.

Safe Harbor

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Act of 1934, as amended, relating to the company's future growth and its ability to return to profitability. Actual results could differ materially and adversely from those projected in the forward-looking statements based on, among other things, the company's ability to effectively integrate the aest
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Blair Offers James Support To Fight AIDS
2. James Cook University urges more medical seats
3. Wood Appointed As the First Chair of SAADAT
4. Yoga Guru appointed Bihars brand ambassador
5. Disappointed Students Plan To Intensify Agitation Nationwide
6. City Surgeon Appointed Adviser To Armed Forces
7. Indian-American Appointed for US Hospital Top Post
8. Retiring Government Doctors to Be Reappointed to Overcome Paucity of Specialists
9. Study casts doubt on keyboard ills
10. Who Board To Discuss Asian Tsunami Related Health Issues
11. Abdominal Crunches Not The Best Option For Wash Board Abs.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...ysfunction, a problem few men discuss with their p...ascular disease. Risk factors associated with card...holesterol, obesity and smoking are the same as th...at Erectile dysfunction affects 40 million men, ye...
...t from the Indian capital, the SARS virus has incr... affected countries like China approaching the Ind...es. Macrolides are a family of antibiotics that tr...ections. While doctors are still battling with the...
...cademy of Pediatrics has reported that all infants...given vitamin D to help prevent rickets, a potenti...o grow straight and strong. While breast milk is t...enough vitamin D to meet babies needs. This happen...
...by researchers from Harvard Medical School has sho...y run over twice the risk of a stroke caused by bl...ntified a link between ischemic stroke - caused by... smoking. The new study that covered 22,022 male U...
Other Medicine News:
(Date:10/6/2008)...E, Oct. 6 /- Dendreon Corpo...today, Monday, October 6, 2008 at 9:00 AM,ET (6:00...sis of its IMPACT,(IMmunotherapy for Prostate Aden...al trial of PROVENGE(R) (sipuleucel-T), the Compan...for the treatment of advanced prostate,cancer., ...
(Date:10/3/2008)...DAM, October 3 /- Amsterdam...in the field of human gene therapy,announced toda...nto the,Marketing Authorization Application (MAA) ...LPLD), a seriously debilitating and potentially le...phase II clinical studies (22,patients in total) d...
(Date:10/2/2008)...Robert Weiss, Director of Maryland Laser, Skin and...ctice -, BALTIMORE, Oct. 2 /- Robert...ong the first physicians in the U.S. to offer his,... the latest,state-of-the-art procedure in laser s...enowned dermatologist, who is in private practice ...
(Date:10/2/2008)... Indicate Dual Modes of Action and Synergy with Ch... -- Access Pharmaceuticals, Inc.,(OTC Bulletin Boa...l,studies on Angiolix showing that by blocking lac...ect as well as a direct anti-proliferative effect ...an breast cancer (MX-1),Angiolix had a significan...
Breaking Medicine Technology:Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3Milton Frank Appointed COO of Life Recovery Systems 23589 1Milton Frank Appointed COO of Life Recovery Systems 23589 2Pennsylvania Governor Rendell Signs Bill Ensuring Continuity of Care for Children Young Adults with Autism 23585 1Pennsylvania Governor Rendell Signs Bill Ensuring Continuity of Care for Children Young Adults with Autism 23585 2Depression after stroke 3A A neglected problem 23583 1Depression after stroke 3A A neglected problem 23583 2Depression after stroke 3A A neglected problem 23583 3Aerosol toxins from red tides may cause long term health threat 3962 1Aerosol toxins from red tides may cause long term health threat 3962 2
...4, 2007 - Cytos,Biotechnology AG (SWX:CYTN) report...-blind combined phase I/IIa study with,CYT007-TNFQ...psoriasis and other inflammatory conditions. The p...l and included 48 patients,suffering from moderate...e study, the safety and tolerability of ascending ...
... Biotechnology Corporation,(NasdaqCM:GNBT) announc...nobiology at its wholly-owned Antigen Express subs...t strategy at an,international conference in Londo...Anti-Infective Agents - Challenges and,Opportuniti...ectives-forum.com">www.anti-infectives-forum.com )...
Other Medicine Technology:Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 2Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 3
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates.
Bagolini's striated lenses consists of 2 circular lenses in a metal frame with tabs for use by the examiner.
BD Visitec IOL Manipulator, blunt tip, formed 10.0mm from end. Fits 0.20mm diameter holes & larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge indicating positio
BD Visitec™ button tip manipulator, 0.50 mm diameter button tip angled 45, 15.0 mm from end (3/bx, 1 bx/ca). May be used for IOL manipulation or iris retraction. Sterile.
Medicine Products: